The Australian and New Zealand Registry of Advanced Glaucoma aims to provide the world's largest cohort of advanced glaucoma cases with clinical information and DNA to ascertain new glaucoma risk profiles.
Glaucoma blindness can in most cases be prevented if those at high risk of developing the disease are identified and treated appropriately at an early stage. Many people at high risk are asymptomatic in the early stages, and so are not diagnosed until irreversible vision loss has occurred.
Better identification of those people at high risk of glaucoma would result in an overall reduction of preventable blindness by treating the condition before serious sight loss has occurred.
Download Forms
